Your browser doesn't support javascript.
loading
Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch, Alexander H; Lyko, Raphael; Nilsson, Lars-Göran; Beck, Werner; Amdahl, Michael; Lechner, Petra; Schneider, Andreas; Wanner, Christoph; Rosenkranz, Alexander R; Krieter, Detlef H.
Afiliação
  • Kirsch AH; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Lyko R; Division of Nephrology, Department of Medicine, University Hospital, Würzburg, Germany.
  • Nilsson LG; Gambro Lundia AB, Baxter Renal Therapeutic Area, Lund, Sweden.
  • Beck W; Gambro Dialysatoren GmbH, Baxter Renal Therapeutic Area, Hechingen, Germany.
  • Amdahl M; Baxter Healthcare Corporation, Life Science & Operations, Round Lake, IL, USA.
  • Lechner P; Department of Internal Medicine, LKH Hochsteiermark, Bruck, Austria.
  • Schneider A; Division of Nephrology, Department of Medicine, University Hospital, Würzburg, Germany.
  • Wanner C; Division of Nephrology, Department of Medicine, University Hospital, Würzburg, Germany.
  • Rosenkranz AR; Clinical Division of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Krieter DH; Division of Nephrology, Department of Medicine, University Hospital, Würzburg, Germany.
Nephrol Dial Transplant ; 32(1): 165-172, 2017 01 01.
Article em En | MEDLINE | ID: mdl-27587605
ABSTRACT

Background:

Compared to high-flux dialysis membranes, novel medium cut-off (MCO) membranes show greater permeability for larger middle molecules.

Methods:

In two prospective, open-label, controlled, randomized, crossover pilot studies, 39 prevalent hemodialysis (HD) patients were studied in four dialysis treatments as follows study 1, three MCO prototype dialyzers (AA, BB and CC with increasing permeability) and one high-flux dialyzer in HD; and study 2, two MCO prototype dialyzers (AA and BB) in HD and high-flux dialyzers in HD and hemodiafiltration (HDF). Primary outcome was lambda free light chain (λFLC) overall clearance. Secondary outcomes included overall clearances and pre-to-post-reduction ratios of middle and small molecules, and safety of MCO HD treatments.

Results:

MCO HD provided greater λFLC overall clearance [least square mean (standard error)] as follows study 1 MCO AA 8.5 (0.54), MCO BB 11.3 (0.51), MCO CC 15.0 (0.53) versus high-flux HD 3.6 (0.51) mL/min; study 2 MCO AA 10.0 (0.58), MCO BB 12.5 (0.57) versus high-flux HD 4.4 (0.57) and HDF 6.2 (0.58) mL/min. Differences between MCO and high-flux dialyzers were consistently significant in mixed model analysis (each P < 0.001). Reduction ratios of λFLC were greater for MCO. Clearances of α1-microglobulin, complement factor D, kappa FLC (κFLC) and myoglobin were generally greater with MCO than with high-flux HD and similar to or greater than clearances with HDF. Albumin loss was moderate with MCO, but greater than with high-flux HD and HDF.

Conclusions:

MCO HD removes a wide range of middle molecules more effectively than high-flux HD and even exceeds the performance of high-volume HDF for large solutes, particularly λFLC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Hemodiafiltração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diálise Renal / Hemodiafiltração Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Assunto da revista: NEFROLOGIA / TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria